Synonyms: APL-101 | bozitinib | PLB1001
Compound class:
Synthetic organic
Comment: We obtained the chemical structure for vebreltinib from WHO Proposed list 125 of July 2021. This mapped to PubChem CID 72202701. Synonyms for vebreltinib (from PubChem) include APL-101 and PLB-1001 [1]. Vebreltinib is an oral, ATP-competitive MET kinase inhibitor that is active against MET-altered tumour cells in preclinical models. It can cross the blood-brain barrier.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine |
International Nonproprietary Names | |
INN number | INN |
11677 | vebreltinib |
Synonyms |
APL-101 | bozitinib | PLB1001 |
Database Links | |
BindingDB Ligand | 107096 |
CAS Registry No. | 1440964-89-5 (source: WHO INN record) |
GtoPdb PubChem SID | 442878703 |
PubChem CID | 72202701 |
Search Google for chemical match using the InChIKey | QHXLXUIZUCJRKV-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | QHXLXUIZUCJRKV |
Search PubMed clinical trials | vebreltinib |
Search PubMed titles | vebreltinib |
Search PubMed titles/abstracts | vebreltinib |
UniChem Compound Search for chemical match using the InChIKey | QHXLXUIZUCJRKV-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | QHXLXUIZUCJRKV-UHFFFAOYSA-N |